Netherlands - Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Netherlands Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale was up 15.6% year on year. At €1,156,477,859.06 in 2019, the country was number 8 among other countries in Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Netherlands is overtaken by Sweden, which was number 7 with €1,420,967,812.89 and is followed by Ireland at €832,081,841.9. France lead the ranking with €4,561,958,734.8 in 2019, a growth of 2.9% compared to 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Malta witnessed the best average annual growth at +35.2% per year, while Finland was the worst growing country at -24.5% per year.

Loading...

Date Euros
2019 1,156,477,859.06
2018 1,154,644,840.00
2017 1,014,662,030.00
2016 804,442,420.00
2015 789,607,530.00
Download all data from 1995 to 2019

How does Netherlands rank in Export of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 27 Countries Euros Last YoY 5‑years CAGR
1 #1
France
4,561,958,734.80 2019 +2.9 % +15.9 % View data
2 #2
Belgium
3,690,243,246.91 2019 +3.3 % +4.2 % View data
7 #7
Sweden
1,420,967,812.89 2019 +8.6 % -2.8 % View data
8 #8
Netherlands
1,156,477,859.06 2019 +0.2 % +15.6 % View data
9 #9
Ireland
832,081,841.90 2019 +3.2 % +7.9 % View data
Compare all 27 countries

Go Top